P. Devereaux, B. Manns, W. Ghali, H. Quan, and G. Guyatt, Physician Interpretations and Textbook Definitions of Blinding Terminology in Randomized Controlled Trials, JAMA, vol.285, issue.15, pp.2000-2003, 2001.
DOI : 10.1001/jama.285.15.2000

K. Schulz, I. Chalmers, and D. Altman, The Landscape and Lexicon of Blinding in Randomized Trials, Annals of Internal Medicine, vol.136, issue.3, pp.254-259, 2002.
DOI : 10.7326/0003-4819-136-3-200202050-00022

K. Schulz and D. Grimes, Blinding in randomised trials: hiding who got what, The Lancet, vol.359, issue.9307, pp.696-700, 2002.
DOI : 10.1016/S0140-6736(02)07816-9

K. Schulz, I. Chalmers, R. Hayes, and D. Altman, Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials, JAMA: The Journal of the American Medical Association, vol.273, issue.5, pp.408-412, 1995.
DOI : 10.1001/jama.273.5.408

K. Schulz, D. Grimes, D. Altman, and R. Hayes, Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology, BMJ, vol.312, issue.7033, pp.742-744, 1996.
DOI : 10.1136/bmj.312.7033.742

L. Gluud, Bias in Clinical Intervention Research, American Journal of Epidemiology, vol.163, issue.6, pp.493-501, 2006.
DOI : 10.1093/aje/kwj069

A. Hrobjartsson and P. Gotzsche, Is the Placebo Powerless? An Analysis of Clinical Trials Comparing Placebo With no Treatment, Obstetrical and Gynecological Survey, vol.56, issue.10, pp.1594-1602, 2001.
DOI : 10.1097/00006254-200110000-00021

A. Hrobjartsson, What are the main methodological problems in the estimation of placebo effects?, Journal of Clinical Epidemiology, vol.55, issue.5, pp.430-435, 2002.
DOI : 10.1016/S0895-4356(01)00496-6

J. Noseworthy, G. Ebers, M. Vandervoort, R. Farquhar, and E. Yetisir, The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial, Neurology, vol.44, issue.1, pp.16-20, 1994.
DOI : 10.1212/WNL.44.1.16

N. Desbiens, In randomized controlled trials, should subjects in both placebo and drug groups be expected to guess that they are taking drug 50% of the time?, Medical Hypotheses, vol.59, issue.3, pp.227-232, 2002.
DOI : 10.1016/S0306-9877(02)00205-0

N. Desbiens, Lessons Learned from Attempts To Establish the Blind in Placebo-Controlled Trials of Zinc for the Common Cold, Annals of Internal Medicine, vol.133, issue.4, pp.302-303, 2000.
DOI : 10.7326/0003-4819-133-4-200008150-00016

T. Scientific, Journal citation reports Available: http:// isiwebofknowledge.com. Accessed, 2003.

I. Boutron, F. Tubach, B. Giraudeau, and P. Ravaud, Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials, Journal of Clinical Epidemiology, vol.57, issue.6, pp.543-550, 2004.
DOI : 10.1016/j.jclinepi.2003.12.010

A. Hrobjartsson, E. Forfang, M. Haahr, B. Als-nielsen, and S. B. , Testing the success of blinding in randomised clinical trials [abstract]. 12th Cochrane Colloquium: Bridging the Gaps, pp.138-139, 2004.

I. Boutron, C. Estellat, and P. Ravaud, A review of blinding in randomized controlled trials found results inconsistent and questionable, Journal of Clinical Epidemiology, vol.58, issue.12, pp.1220-1226, 2005.
DOI : 10.1016/j.jclinepi.2005.04.006

D. Fergusson, K. Glass, D. Waring, and S. Shapiro, Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials, BMJ, vol.328, issue.7437, p.432, 2004.
DOI : 10.1136/bmj.37952.631667.EE

S. Fiorucci, A. Mencarelli, A. Meneguzzi, A. Lechi, and B. Renga, Co-Administration of Nitric Oxide-Aspirin (NCX-4016) and Aspirin Prevents Platelet and Monocyte Activation and Protects Against Gastric Damage Induced by Aspirin in Humans, Journal of the American College of Cardiology, vol.44, issue.3, pp.635-641, 2004.
DOI : 10.1016/j.jacc.2004.03.079

O. 'brien, L. Taddio, A. Ipp, M. Goldbach, M. Koren et al., Topical 4% Amethocaine Gel Reduces the Pain of Subcutaneous Measles-Mumps-Rubella Vaccination, PEDIATRICS, vol.114, issue.6, pp.720-724, 2004.
DOI : 10.1542/peds.2004-0722

A. Gerritsen, H. De-vet, R. Scholten, F. Bertelsmann, and M. De-krom, Splinting vs Surgery in the Treatment of Carpal Tunnel Syndrome, JAMA, vol.288, issue.10, pp.1245-1251, 2002.
DOI : 10.1001/jama.288.10.1245

C. Francis, S. Berkowitz, P. Comp, J. Lieberman, and J. Ginsberg, Comparison of Ximelagatran with Warfarin for the Prevention of Venous Thromboembolism after Total Knee Replacement, New England Journal of Medicine, vol.349, issue.18, pp.1703-1712, 2003.
DOI : 10.1056/NEJMoa035162

C. Antoni, G. Krueger, K. De-vlam, C. Birbara, and A. Beutler, Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial, Annals of the Rheumatic Diseases, vol.64, issue.8, pp.1227-1236, 2005.
DOI : 10.1136/ard.2004.032268

M. Flaten, T. Simonsen, K. Zahlsen, T. Aamo, and G. Sager, Stimulant and relaxant drugs combined with stimulant and relaxant information: a study of active placebo, Psychopharmacology, vol.8, issue.3-4, pp.426-434, 2004.
DOI : 10.1007/s00213-004-1886-7

C. Wu, P. Tella, P. Staats, R. Vaslav, and D. Kazim, Analgesic Effects of Intravenous Lidocaine and Morphine on Postamputation Pain, Anesthesiology, vol.96, issue.4, pp.841-848, 2002.
DOI : 10.1097/00000542-200204000-00010

P. Dellemijn and J. Vanneste, Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain, The Lancet, vol.349, issue.9054, pp.753-758, 1997.
DOI : 10.1016/S0140-6736(96)09024-1

R. Shaw, Randomized Controlled Trial of Syn-Ergel and an Active Placebo in the Treatment of Heartburn of Pregnancy, Journal of International Medical Research, vol.52, issue.2, pp.147-151, 1978.
DOI : 10.1177/030006057800600215

S. Edward, A. Stevens, D. Braunholtz, R. Lilford, and T. Swift, The Ethics of Placebo-controlled Trials: A Comparison of Inert and Active Placebo Controls, World Journal of Surgery, vol.20, issue.3 Suppl, pp.610-614, 2005.
DOI : 10.1007/s00268-005-7621-7

A. Nanda, O. Connor, M. Anand, M. Dreskin, S. C. Zhang et al., Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract, Journal of Allergy and Clinical Immunology, vol.114, issue.6, pp.1339-1344, 2004.
DOI : 10.1016/j.jaci.2004.08.049

D. Moher, B. Pham, A. Jones, D. Cook, and A. Jadad, Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?, The Lancet, vol.352, issue.9128, pp.609-613, 1998.
DOI : 10.1016/S0140-6736(98)01085-X

D. Altman, K. Schulz, D. Moher, M. Egger, and F. Davidoff, The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration, Annals of Internal Medicine, vol.134, issue.8, pp.663-694, 2001.
DOI : 10.7326/0003-4819-134-8-200104170-00012

A. Prasad, J. Fitzgerald, B. Bao, F. Beck, and P. Chandrasekar, Duration of Symptoms and Plasma Cytokine Levels in Patients with the Common Cold Treated with Zinc Acetate, Annals of Internal Medicine, vol.133, issue.4, pp.245-252, 2000.
DOI : 10.7326/0003-4819-133-4-200008150-00006

A. Jadad, R. Moore, D. Carroll, C. Jenkinson, and D. Reynolds, Assessing the quality of reports of randomized clinical trials: Is blinding necessary?, Controlled Clinical Trials, vol.17, issue.1, pp.1-12, 1996.
DOI : 10.1016/0197-2456(95)00134-4

A. Verhagen, H. De-vet, R. De-bie, M. Boers, and P. Van-den-brandt, The art of quality assessment of RCTs included in systematic reviews, Journal of Clinical Epidemiology, vol.54, issue.7, pp.651-654, 2001.
DOI : 10.1016/S0895-4356(00)00360-7

A. Verhagen, H. De-vet, R. De-bie, A. Kessels, and M. Boers, The Delphi List, Journal of Clinical Epidemiology, vol.51, issue.12, pp.1235-1241, 1998.
DOI : 10.1016/S0895-4356(98)00131-0

I. Boutron, D. Moher, P. Tugwell, B. Giraudeau, and S. Poiraudeau, A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus, Journal of Clinical Epidemiology, vol.58, issue.12, pp.1233-1240, 2005.
DOI : 10.1016/j.jclinepi.2005.05.004

J. Pildal, A. Chan, A. Hrobjartsson, E. Forfang, and D. Altman, Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study, BMJ, vol.330, issue.7499, p.1049, 2005.
DOI : 10.1136/bmj.38414.422650.8F